CN111373052A - 非编码RNA(ncRNA)用于认知障碍的诊断 - Google Patents

非编码RNA(ncRNA)用于认知障碍的诊断 Download PDF

Info

Publication number
CN111373052A
CN111373052A CN201880068913.3A CN201880068913A CN111373052A CN 111373052 A CN111373052 A CN 111373052A CN 201880068913 A CN201880068913 A CN 201880068913A CN 111373052 A CN111373052 A CN 111373052A
Authority
CN
China
Prior art keywords
lnc
mir
lncrnas
listed
mirnas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201880068913.3A
Other languages
English (en)
Chinese (zh)
Inventor
H·菲拉特
S·穆萨维
E·朔尔丹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amonetta Diagnostics
Original Assignee
Amonetta Diagnostics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amonetta Diagnostics filed Critical Amonetta Diagnostics
Publication of CN111373052A publication Critical patent/CN111373052A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN201880068913.3A 2017-09-05 2018-09-05 非编码RNA(ncRNA)用于认知障碍的诊断 Pending CN111373052A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762554427P 2017-09-05 2017-09-05
US62/554,427 2017-09-05
PCT/EP2018/073905 WO2019048500A1 (en) 2017-09-05 2018-09-05 NON-CODING RNA (RNANC) FOR THE DIAGNOSIS OF COGNITIVE DISORDERS

Publications (1)

Publication Number Publication Date
CN111373052A true CN111373052A (zh) 2020-07-03

Family

ID=63517886

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880068913.3A Pending CN111373052A (zh) 2017-09-05 2018-09-05 非编码RNA(ncRNA)用于认知障碍的诊断

Country Status (5)

Country Link
US (1) US11718879B2 (https=)
EP (1) EP3679157B1 (https=)
JP (1) JP7398806B2 (https=)
CN (1) CN111373052A (https=)
WO (1) WO2019048500A1 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111690739A (zh) * 2020-07-31 2020-09-22 上海市精神卫生中心（上海市心理咨询培训中心） Mci诊断标志物、mci诊断试剂盒及相应的检测方法
CN112779331A (zh) * 2021-02-05 2021-05-11 浙江萧山医院 一种血管痴呆血清外泌体microRNAs标志物及其应用
CN113234812A (zh) * 2021-06-09 2021-08-10 济南帕斯维德生物科技有限公司 一种用于诊断阿尔茨海默病的诊断试剂

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4498086A3 (en) * 2018-02-13 2025-04-02 Toray Industries, Inc. Kit or device and method for detecting dementia
WO2021201092A1 (ja) 2020-03-31 2021-10-07 東レ株式会社 海馬萎縮を検出するためのキット又はデバイス及び方法
KR102555878B1 (ko) * 2020-04-23 2023-07-17 주식회사 바이오오케스트라 하향조절된 mirna의 진단 및 치료를 위한 용도
KR102691806B1 (ko) * 2020-04-23 2024-08-06 주식회사 바이오오케스트라 상향조절된 mirna의 진단 및 치료를 위한 용도
CN113373230B (zh) * 2021-06-18 2022-07-29 福建医科大学附属第一医院 检测生物标志物的试剂在诊断胃癌中的应用
JP2023004314A (ja) * 2021-06-25 2023-01-17 株式会社堀場製作所 心理的ストレスの検出方法及び検出用キット
JP7840033B2 (ja) * 2021-11-02 2026-04-03 学校法人日本医科大学 オキサリプラチン誘発性末梢神経障害バイオマーカー
WO2025011736A1 (en) 2023-07-07 2025-01-16 Genxpro Gmbh A METHOD FOR AN IN VITRO DIAGNOSIS, PROGNOSIS, STAGING AND/OR TREATMENT MONITORING OF A NEURODEGENERATIVE DISEASE, NEUROLOGICAL DISEASE OR AMYLOID β-RELATED DISEASE
CN119020481B (zh) * 2024-08-29 2026-01-30 河络新图生物科技(上海)有限公司 检测xcl2基因表达的物质在制备检测帕金森病产品中的应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013024469A1 (en) * 2011-08-16 2013-02-21 Rosetta Genomics Ltd. Methods and compositions for diagnosis of alzheimer's desease
WO2014075911A1 (en) * 2012-11-16 2014-05-22 Siemens Aktiengesellschaft Diagnostic mirna markers for alzheimer
US20140272993A1 (en) * 2013-03-15 2014-09-18 The Translational Genomics Research Institute Method of sequencing a full microrna profile from cerebrospinal fluid
WO2015031958A1 (en) * 2013-09-06 2015-03-12 Garvan Institute Of Medical Research Regulatory molecules
CN105950705A (zh) * 2015-04-08 2016-09-21 中国人民解放军第二军医大学 一组microRNAs在制备阿尔兹海默氏症诊断试剂或诊断试剂盒中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407132B1 (en) 1997-07-25 2002-06-18 James Black Foundation Limited Substituted imidazole derivatives and their use as histamine H3 receptor ligands
AU2005206389A1 (en) 2004-01-27 2005-08-04 Compugen Ltd. Methods of identifying putative gene products by interspecies sequence comparison and biomolecular sequences uncovered thereby
FR2882056B1 (fr) 2005-02-15 2007-06-01 Centre Nat Rech Scient Dipyrromethenes-bore borocarbones insatures
US9377472B2 (en) 2012-04-30 2016-06-28 Amoneta Diagnostics Biological complex specific for Alzheimer's disease detection in vitro and use thereof
WO2015179909A1 (en) * 2014-05-26 2015-12-03 The University Of Melbourne Mirna biomarkers of alzheimer's disease
EP3184646B1 (de) * 2015-12-22 2019-04-17 Siemens Aktiengesellschaft Spezifische signaturen in alzheimer durch multizentrische mirna-profile
WO2020049135A1 (en) 2018-09-05 2020-03-12 Amoneta Diagnostics Sas Long non-coding rnas (lncrnas) for the diagnosis and therapeutics of brain disorders, in particular cognitive disorders

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013024469A1 (en) * 2011-08-16 2013-02-21 Rosetta Genomics Ltd. Methods and compositions for diagnosis of alzheimer's desease
WO2014075911A1 (en) * 2012-11-16 2014-05-22 Siemens Aktiengesellschaft Diagnostic mirna markers for alzheimer
US20140272993A1 (en) * 2013-03-15 2014-09-18 The Translational Genomics Research Institute Method of sequencing a full microrna profile from cerebrospinal fluid
WO2015031958A1 (en) * 2013-09-06 2015-03-12 Garvan Institute Of Medical Research Regulatory molecules
CN105950705A (zh) * 2015-04-08 2016-09-21 中国人民解放军第二军医大学 一组microRNAs在制备阿尔兹海默氏症诊断试剂或诊断试剂盒中的应用

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
JOHN P COGSWELL等: "Identification of miRNA Changes in Alzheimer\'s Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways", J ALZHEIMERS DIS, vol. 14, no. 1, 31 May 2008 (2008-05-31), pages 27 - 41 *
JUN-ICHI SATOH等: "MicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer\'s Disease from Public Data", BIOMARK INSIGHTS, vol. 10, 15 April 2015 (2015-04-15), pages 21 - 31 *
XIAOLIN ZHOU等: "Identification of Alzheimer\'s disease-associated long noncoding RNAs", NEUROBIOL AGING, vol. 36, no. 11, 30 November 2015 (2015-11-30), pages 2925 - 2931 *
刘辰庚等: "microRNA-135a在阿尔茨海默病患者中的检测价值", 中国老年学杂志, vol. 36, no. 1, 31 January 2016 (2016-01-31), pages 152 - 153 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111690739A (zh) * 2020-07-31 2020-09-22 上海市精神卫生中心（上海市心理咨询培训中心） Mci诊断标志物、mci诊断试剂盒及相应的检测方法
WO2022022060A1 (zh) * 2020-07-31 2022-02-03 上海市精神卫生中心（上海市心理咨询培训中心） Mci诊断标志物、mci诊断试剂盒及相应的检测方法
CN111690739B (zh) * 2020-07-31 2022-09-16 上海市精神卫生中心（上海市心理咨询培训中心） Mci诊断标志物、mci诊断试剂盒及相应的检测方法
CN112779331A (zh) * 2021-02-05 2021-05-11 浙江萧山医院 一种血管痴呆血清外泌体microRNAs标志物及其应用
CN113234812A (zh) * 2021-06-09 2021-08-10 济南帕斯维德生物科技有限公司 一种用于诊断阿尔茨海默病的诊断试剂
CN113234812B (zh) * 2021-06-09 2023-11-03 科德角国际生物医学科技(北京)有限公司 一种用于诊断阿尔茨海默病的诊断试剂

Also Published As

Publication number Publication date
JP2020536503A (ja) 2020-12-17
EP3679157A1 (en) 2020-07-15
EP3679157B1 (en) 2024-12-18
US11718879B2 (en) 2023-08-08
JP7398806B2 (ja) 2023-12-15
WO2019048500A1 (en) 2019-03-14
EP3679157C0 (en) 2024-12-18
US20210071252A1 (en) 2021-03-11

Similar Documents

Publication Publication Date Title
US12344895B2 (en) Long non-coding RNAS (LNCRNAS) for the diagnosis and therapeutics of brain disorders, in particular cognitive disorders
JP7398806B2 (ja) 認知障害の診断用のノンコーディングＲＮＡ（ｎｃＲＮＡ）
CN103620057B (zh) 使用来自体液的miRNA来早期检测和监控轻度认知障碍(MCI)和阿尔茨海默病(AD)的方法
Fransquet et al. Micro RNA as a potential blood-based epigenetic biomarker for Alzheimer's disease
EP3891295B1 (en) Methods of diagnosing a disease state
US20200332361A1 (en) Method for assisting detection of alzheimer's disease or mild cognitive impairment
TWI580788B (zh) 用於檢測川崎病的方法及套組
CN104981548A (zh) 用于阿尔茨海默氏病的诊断性miRNA标志物
EP3433381B1 (en) Methods of using mirnas from bodily fluids for detection and differentiation of neurodegenerative diseases
CN108359711A (zh) 解析和定量无细胞rna的方法
WO2015069900A1 (en) Methods for profiliing and quantitating cell-free rna
US20190136320A1 (en) Microrna biomarkers in blood for diagnosis of alzheimer's disease
WO2021142417A2 (en) Systems for detecting alzheimer's disease
EP4185713A1 (en) Biomarkers for cognitive conditions
CN108531571B (zh) 用于检测注意力缺陷/过动症的方法和试剂盒
CN113151450A (zh) 一种用于散发性肌萎缩性侧索硬化症和帕金森病早期诊断的生物标志物及其应用
Kerrebijn Elucidating cell types associated with case-control differences in cortical thickness in neuropsychiatric disorders
US20200308647A1 (en) Mirnas as biomarkers for alzheimer's disease
CN116769899A (zh) 血浆外泌体中has-miR-196在吗啡/海洛因依赖临床诊断和评估中的应用
HK1225759B (zh) 用於检测川崎病的方法及试剂盒

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20200703

RJ01 Rejection of invention patent application after publication